{"id":279,"date":"2024-09-04T03:20:01","date_gmt":"2024-09-04T03:20:01","guid":{"rendered":"https:\/\/clear-ad.org\/?page_id=279"},"modified":"2026-03-31T16:08:54","modified_gmt":"2026-03-31T16:08:54","slug":"presentations","status":"publish","type":"page","link":"https:\/\/clear-ad.org\/index.php\/presentations\/","title":{"rendered":"Presentations"},"content":{"rendered":"\n<table id=\"tablepress-2\" class=\"tablepress tablepress-id-2\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\"><strong>Lead Author<\/strong><\/th><th class=\"column-2\"><strong>Abstract Type<\/strong><\/th><th class=\"column-3\"><strong>Title<\/strong><\/th><th class=\"column-4\"><strong>Date<\/strong><\/th><th class=\"column-5\"><strong>Event Name<\/strong><\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\">Andrew Saykin<\/td><td class=\"column-2\">Virtual Presentation<\/td><td class=\"column-3\">Linking Central and Peripheral ADRD Related Changes: A Decade of Synergy Between the AD Metabolomics and Other Consortia including ADNI and CLEAR-AD<\/td><td class=\"column-4\">12\/11\/2025<\/td><td class=\"column-5\">Alzheimer\u2019s Gut Microbiome Project (AGMP) Annual Meeting &amp; External Advisory Board Meeting<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">Lindsey Kuchenbecker<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Untargeted proteomics and machine learning reveal novel biomarker candidates capturing diverse perturbed pathways in Alzheimer\u2019s disease in an African American cohort<\/td><td class=\"column-4\">12\/2\/2025<\/td><td class=\"column-5\">Clinical Trials on Alzheimer&#8217;s Disease<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">Charisse Winston<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Pre-analytical Characterization of CNS-Derived Extracellular Vesicles from Human Saliva: Effect of Room Temperature and Cellular Origin<\/td><td class=\"column-4\">11\/18\/2025<\/td><td class=\"column-5\">Society for Neuroscience<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">Shiwei Liu<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Epigenetic signatures as indicators of Alzheimer\u2019s Disease (AD)<\/td><td class=\"column-4\">11\/16\/2025<\/td><td class=\"column-5\">Society for Neuroscience &#8211; Neuroscience 2025<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">Ozkan Is<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Profiling microglia from Alzheimer\u2019s disease rare risk variant carriers reveal protective and risk signatures<\/td><td class=\"column-4\">11\/15\/2025<\/td><td class=\"column-5\">Society For Neuroscience<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\">Andrew Saykin<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">The Road to Personalized Medicine for Alzheimer\u2019s Disease and Related Dementias<\/td><td class=\"column-4\">11\/1\/2025<\/td><td class=\"column-5\">University of Kentucky ADRC Fifteenth Annual Markesbery Symposium on Aging &amp; Dementia<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\">Andrew Saykin<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Precision Health Strategies for Alzheimer\u2019s Disease and Related Dementias: From Systems Biology to Biomarkers and Therapeutic Targets<\/td><td class=\"column-4\">10\/31\/2025<\/td><td class=\"column-5\">University of Kentucky ADRC Fifteenth Annual Markesbery Symposium on Aging &amp; Dementia<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\">Charisse Winston<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Characterization of Multiple CNS-Derived Salivary EV Populations for Alzheimer&#8217;s Biomarker Discovery<\/td><td class=\"column-4\">10\/30\/2025<\/td><td class=\"column-5\">2nd Annual Extracellular Vesicles in Nervous System (EViNS) Symposium<\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-1\">Adelyn Tsai<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Cell type-specific gene expression changes are associated with cerebral amyloid angiopathy and blood-brain barrier integrity in Alzheimer\u2019s disease<\/td><td class=\"column-4\">7\/30\/2025<\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-11\">\n\t<td class=\"column-1\">Mariet Allen<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Multi-omics studies reveal convergent and divergent pathways in Alzheimer\u2019s and related disorders<\/td><td class=\"column-4\">7\/29\/2025<\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-12\">\n\t<td class=\"column-1\">Vanessa Col\u00f3n Badillo<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Targeted plasma eQTL and pQTL analyses to identify potential novel biomarkers for Alzheimer\u2019s Disease in African Americans<\/td><td class=\"column-4\">7\/28\/2025<\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-13\">\n\t<td class=\"column-1\">Evgeny Chumin<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Preliminary Characterization of Participant-Level Tau Brain Networks in the Health and Aging Brain Study &#8211; Health Disparities HABS-HD Cohort.<\/td><td class=\"column-4\">07\/27\/25<\/td><td class=\"column-5\">Alzheimer\u2019s Association International Conference and the Alzheimer&#8217;s Imaging Consortium<\/td>\n<\/tr>\n<tr class=\"row-14\">\n\t<td class=\"column-1\">Evgeny Chumin<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Functional connectivity network identifiability across a multi-year follow-up in the Korean Brain Aging Study for the Early Diagnosis and Prediction of AD<\/td><td class=\"column-4\">07\/27\/25<\/td><td class=\"column-5\">Alzheimer\u2019s Association International Conference and the Alzheimer&#8217;s Imaging Consortium<\/td>\n<\/tr>\n<tr class=\"row-15\">\n\t<td class=\"column-1\">Ozkan Is<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Single cell study of human brains and microglia discovers microglial protective and risk signatures driven by Alzheimer&#8217;s disease genetic factors.<\/td><td class=\"column-4\">7\/27\/2025<\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-16\">\n\t<td class=\"column-1\">Lindsey Kuchenbecker<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Data-driven plasma biomarker discovery enables accurate classification of Alzheimer\u2019s dementia in an African American cohort<\/td><td class=\"column-4\">7\/27\/2025<\/td><td class=\"column-5\">AAIC<\/td>\n<\/tr>\n<tr class=\"row-17\">\n\t<td class=\"column-1\">Yuhao Min<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">From novel targets to potential therapies: development of antisense oligonucleotides for progressive supranuclear palsy<\/td><td class=\"column-4\">7\/27\/2025<\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-18\">\n\t<td class=\"column-1\">Xuan Chen<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Blood-based genes and co-expression network levels are associated with AD\/MCI diagnosis, cognitive, and neuroimaging phenotypes and preserved in the brain<\/td><td class=\"column-4\">07\/26\/25<\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-19\">\n\t<td class=\"column-1\">Merve Atik<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Identification of Novel Genetic Risk Factors for Cerebral Amyloid Angiopathy<\/td><td class=\"column-4\">07\/26\/25<\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-20\">\n\t<td class=\"column-1\">Andrew Saykin<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Endophenotypes, pathways, and the systems biology of AD\/ADRD<\/td><td class=\"column-4\">06\/22\/25<\/td><td class=\"column-5\">Gordon Research Conference on Alzheimer\u2019s Disease 2025: Multimodal Approaches to Mechanisms and Therapeutic Targets<\/td>\n<\/tr>\n<tr class=\"row-21\">\n\t<td class=\"column-1\">Evgeny Chumin<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Characterization of individual tau-PET networks in Alzheimer\u2019s disease and related dementia<\/td><td class=\"column-4\">06\/14\/25<\/td><td class=\"column-5\">Organization for Human Brain Mapping<\/td>\n<\/tr>\n<tr class=\"row-22\">\n\t<td class=\"column-1\">Andrew Saykin<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Transformative Developments in Alzheimer\u2019s Disease Research and Treatment<\/td><td class=\"column-4\">06\/11\/25<\/td><td class=\"column-5\">Mini-University, Indiana University Alumni Association<\/td>\n<\/tr>\n<tr class=\"row-23\">\n\t<td class=\"column-1\">Andrew Saykin<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Systems Biology, Biomarkers, and Evolving Precision Health Strategies for Alzheimer\u2019s Disease<\/td><td class=\"column-4\">05\/30\/25<\/td><td class=\"column-5\">Michigan ADRC Annual Symposium<\/td>\n<\/tr>\n<tr class=\"row-24\">\n\t<td class=\"column-1\">Ozkan Is<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Profiling Microglia with Rare AD Variant Carriers<\/td><td class=\"column-4\">04\/04\/25<\/td><td class=\"column-5\">AD\/PD 2025<\/td>\n<\/tr>\n<tr class=\"row-25\">\n\t<td class=\"column-1\">Andrew Saykin<\/td><td class=\"column-2\">Virtual Presentation<\/td><td class=\"column-3\">PET as an Endophenotype for Genetic Studies of AD\/ADRD<\/td><td class=\"column-4\">03\/12\/25<\/td><td class=\"column-5\">Novel Opportunities for PET Imaging Tracers in AD\/ADRD and Emerging Tracers Workshop<\/td>\n<\/tr>\n<tr class=\"row-26\">\n\t<td class=\"column-1\">Andrew Saykin<\/td><td class=\"column-2\">Virtual Presentation<\/td><td class=\"column-3\">Global proteomics approaches for deep characterization of CSF and matched plasma of cross-sectional and longitudinal samples from ADNI<\/td><td class=\"column-4\">02\/20\/25<\/td><td class=\"column-5\">ADNI Biofluid Biomarker Working Group<\/td>\n<\/tr>\n<tr class=\"row-27\">\n\t<td class=\"column-1\">Olatunbosun Arowolo<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">A pilot study on the association of plasma proteins with neuroimaging biomarkers of Alzheimer\u2019s disease in African Americans<\/td><td class=\"column-4\">01\/14\/25<\/td><td class=\"column-5\">Human Amyloid Imaging Conference<\/td>\n<\/tr>\n<tr class=\"row-28\">\n\t<td class=\"column-1\">Cheyenne Hurst<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Integration of network analysis of the plasma proteome with Alzheimer\u2019s disease neuroimaging outcomes in an African American cohort<\/td><td class=\"column-4\">01\/14\/25<\/td><td class=\"column-5\">Human Amyloid Imaging conference<\/td>\n<\/tr>\n<tr class=\"row-29\">\n\t<td class=\"column-1\">Lindsey Kuchenbecker<\/td><td class=\"column-2\">Other<\/td><td class=\"column-3\">Integration of data-driven biomarker discovery with established Alzheimer\u2019s disease biomarkers in an African American cohort<\/td><td class=\"column-4\">01\/13\/25<\/td><td class=\"column-5\">Human Amyloid Imaging<\/td>\n<\/tr>\n<tr class=\"row-30\">\n\t<td class=\"column-1\">Andrew Saykin<\/td><td class=\"column-2\">Virtual Presentation<\/td><td class=\"column-3\">Precision Health in Alzheimer\u2019s Disease: Systems Biology, Biomarkers and Prospects for Targeted Therapeutics<\/td><td class=\"column-4\">10\/25\/24<\/td><td class=\"column-5\">Cleveland Clinic Genome Center<\/td>\n<\/tr>\n<tr class=\"row-31\">\n\t<td class=\"column-1\">Andrew Saykin<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Progress in the Genetics of Alzheimer\u2019s Disease<\/td><td class=\"column-4\">09\/23\/24<\/td><td class=\"column-5\">2024 NIA AD Summit<\/td>\n<\/tr>\n<tr class=\"row-32\">\n\t<td class=\"column-1\">Samanth Strickland<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Preserved transcriptional networks in immune signaling pathways associated with chronic disease identified in Alzheimer\u2019s disease and Parkinson\u2019s disease, cross-tissue analysis<\/td><td class=\"column-4\">08\/01\/24<\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-33\">\n\t<td class=\"column-1\">Adelyn Tsai<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Discovery of Genes Underlying Cognitive Resilience in Individuals Predisposed to Alzheimer\u2019s Disease Risk<\/td><td class=\"column-4\">07\/31\/24<\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-34\">\n\t<td class=\"column-1\">Xuan Chen<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Blood-based gene and co-expression network levels are associated with AD\/MCI diagnosis and cognitive phenotypes<\/td><td class=\"column-4\">07\/31\/24<\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-35\">\n\t<td class=\"column-1\">Lindsey Kuchenbecker<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Untargeted plasma proteomics nominates a novel set of plasma biomarkers for Alzheimer\u2019s disease in African Americans<\/td><td class=\"column-4\">07\/30\/24<\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-36\">\n\t<td class=\"column-1\">Joseph Reddy<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Multi-omics profiling of Alzheimer\u2019s disease in multi-ethnic populations<\/td><td class=\"column-4\">07\/29\/24<\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-37\">\n\t<td class=\"column-1\">Shiwei Liu<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Integration of GWAS summary statistics with cell type-specific eQTLs prioritizes potential causal genes for Alzheimer\u2019s disease<\/td><td class=\"column-4\">07\/28\/24<\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-38\">\n\t<td class=\"column-1\">Andrew Saykin<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Enabling Precision Medicine for AD\/ADRD: From Cohort Studies to Clinical Trials<\/td><td class=\"column-4\">07\/26\/24<\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-39\">\n\t<td class=\"column-1\">Thea Rosewood<\/td><td class=\"column-2\">Poster<\/td><td class=\"column-3\">Pathway Enrichment of Longitudinal AD Endophenotypes Identifies Potential Therapeutic Targets for Modifying Disease Trajectory<\/td><td class=\"column-4\"><\/td><td class=\"column-5\">Alzheimer&#8217;s Association International Conference<\/td>\n<\/tr>\n<tr class=\"row-40\">\n\t<td class=\"column-1\">Andrew Saykin<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">The CLEAR-AD Program<\/td><td class=\"column-4\">07\/25\/24<\/td><td class=\"column-5\">7th Annual NIA-AA Symposium &#8211; Enabling Precision Medicine for Alzheimer&#8217;s Disease Through Open Science<\/td>\n<\/tr>\n<tr class=\"row-41\">\n\t<td class=\"column-1\">Andrew Saykin<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">New frontiers in Alzheimer&#8217;s research and therapy: Harnessing data science and systems biology on the way to precision medicine<\/td><td class=\"column-4\">06\/06\/24<\/td><td class=\"column-5\">3rd Annual Big Ten Neuroscience Meeting<\/td>\n<\/tr>\n<tr class=\"row-42\">\n\t<td class=\"column-1\">Andrew Saykin<\/td><td class=\"column-2\">Presentation<\/td><td class=\"column-3\">Decoding Alzheimer\u2019s Disease: A Journey from Imaging Genetics to Systems Biology en Route to Precision Medicine<\/td><td class=\"column-4\">05\/29\/24<\/td><td class=\"column-5\">Statistical Methods in Imaging Conference 2024<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-2 from cache -->","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-279","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/clear-ad.org\/index.php\/wp-json\/wp\/v2\/pages\/279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clear-ad.org\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/clear-ad.org\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/clear-ad.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/clear-ad.org\/index.php\/wp-json\/wp\/v2\/comments?post=279"}],"version-history":[{"count":8,"href":"https:\/\/clear-ad.org\/index.php\/wp-json\/wp\/v2\/pages\/279\/revisions"}],"predecessor-version":[{"id":383,"href":"https:\/\/clear-ad.org\/index.php\/wp-json\/wp\/v2\/pages\/279\/revisions\/383"}],"wp:attachment":[{"href":"https:\/\/clear-ad.org\/index.php\/wp-json\/wp\/v2\/media?parent=279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}